Access

Article


Nature Medicine 11, 183 - 190 (2005)
Published online: 30 January 2005 | doi:10.1038/nm1166

Local and systemic insulin resistance resulting from hepatic activation of IKK-bold beta and NF-kappaB

Dongsheng Cai1, Minsheng Yuan1, Daniel F Frantz1,2, Peter A Melendez1,3, Lone Hansen1, Jongsoon Lee1 & Steven E Shoelson1


We show that NF-kappaB and transcriptional targets are activated in liver by obesity and high-fat diet (HFD). We have matched this state of chronic, subacute 'inflammation' by low-level activation of NF-kappaB in the liver of transgenic mice, designated LIKK, by selectively expressing constitutively active IKK-b in hepatocytes. These mice exhibit a type 2 diabetes phenotype, characterized by hyperglycemia, profound hepatic insulin resistance, and moderate systemic insulin resistance, including effects in muscle. The hepatic production of proinflammatory cytokines, including IL-6, IL-1beta and TNF-alpha, was increased in LIKK mice to a similar extent as induced by HFD in in wild-type mice. Parallel increases were observed in cytokine signaling in liver and mucscle of LIKK mice. Insulin resistance was improved by systemic neutralization of IL-6 or salicylate inhibition of IKK-beta. Hepatic expression of the IkappaBalpha superrepressor (LISR) reversed the phenotype of both LIKK mice and wild-type mice fed an HFD. These findings indicate that lipid accumulation in the liver leads to subacute hepatic 'inflammation' through NF-kappaB activation and downstream cytokine production. This causes insulin resistance both locally in liver and systemically.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Diabetes Aspirin and prevention of diabetes still a topic of debate

Nature Reviews Endocrinology News and Views (01 Jul 2009)